Literature DB >> 24508556

Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.

Kyungchul Kim1, Grant Waterer2, Rachel Thomson3, Ian A Yang4, Najla Nashi1, Dino B A Tan5, Patricia Price6.   

Abstract

Pulmonary disease due to non-tuberculous mycobacteria (NTM) is caused by several species (particularly Mycobacterium avium, Mycobacterium intracellulare) that are abundant in the environment. Th1 cytokines such as interferon (IFN)-γ are important in the control of mycobacteria, but in vitro production of IFN-γ is not deficient in adult patients with pulmonary NTM disease. Antibodies reactive with IFN-γ have been described in patients with disseminated NTM disease, but it is not clear whether they are common in pulmonary disease. Here we show that patients with pulmonary NTM have a higher level of anti-IFN-γ and anti-GM-CSF antibodies than healthy controls, although some controls also have high levels. Levels of anti-IFN-γ antibodies did not correlate with levels of total immunoglobulin. Longitudinal studies are required to determine whether anti-cytokine autoantibodies are consequence rather than a cause of pulmonary NTM disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoantibody; Cytokine; Interferon-γ; Non-tuberculous mycobacteria; Pulmonary disease

Mesh:

Substances:

Year:  2014        PMID: 24508556     DOI: 10.1016/j.cyto.2014.01.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?

Authors:  Fathiah S Amran; Kyungchul Kim; Andrew Lim; Rachel Thomson; Silvia Lee; Grant Waterer; Patricia Price
Journal:  J Clin Immunol       Date:  2016-01-13       Impact factor: 8.317

2.  Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

Authors:  Don Hayes; Rajni Kant Shukla; Yizi Cheng; Emrah Gecili; Marlena R Merling; Rhonda D Szczesniak; Assem G Ziady; Jason C Woods; Luanne Hall-Stoodley; Namal Pm Liyanage; Richard T Robinson
Journal:  JCI Insight       Date:  2022-06-22

Review 3.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 4.  Protein microarrays: a new tool for the study of autoantibodies in immunodeficiency.

Authors:  Jacob M Rosenberg; Paul J Utz
Journal:  Front Immunol       Date:  2015-04-07       Impact factor: 7.561

5.  GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection.

Authors:  Sulayman Benmerzoug; Fabio Vitarelli Marinho; Stéphanie Rose; Claire Mackowiak; David Gosset; Delphine Sedda; Emeline Poisson; Catherine Uyttenhove; Jacques Van Snick; Muazzam Jacobs; Irene Garcia; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

Review 6.  The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.

Authors:  Susan L Baldwin; Sasha E Larsen; Diane Ordway; Gail Cassell; Rhea N Coler
Journal:  PLoS Negl Trop Dis       Date:  2019-02-14

7.  Cytokine and Chemokine Concentrations as Biomarkers of Feline Mycobacteriosis.

Authors:  C O'Halloran; L McCulloch; L Rentoul; J Alexander; J C Hope; D A Gunn-Moore
Journal:  Sci Rep       Date:  2018-11-23       Impact factor: 4.379

8.  Human autoantibodies underlying infectious diseases.

Authors:  Anne Puel; Paul Bastard; Jacinta Bustamante; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2022-03-23       Impact factor: 14.307

Review 9.  The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic Mechanisms.

Authors:  Gregory W Wigger; Tara C Bouton; Karen R Jacobson; Sara C Auld; Samantha M Yeligar; Bashar S Staitieh
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.